Formulation and Characterization of Myricetin Solid Lipid Nanoparticles (SLNs) via Ultrasonication Method
Open Access Health Scientific Journal · 01.08.2026 · 7 (2) · 253-258
DOI: 10.55700/oahsj.v7i2.235 ↗Kurz gefasst
Fachartikel in der Zeitschrift Open Access Health Scientific Journal, online erschienen am 01.08.2026. Verfasst von Dewi Zulfa Rosida und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
Background
Myricetin is a flavonol flavonoid with promising neuroprotective and antioxidant activities. However, its therapeutic application is severely limited by poor water solubility and a low dissolution rate. This study aimed to enhance the solubility and formulation stability of myricetin by developing a Solid Lipid Nanoparticle (SLN) delivery system.
Methods
Myricetin-SLNs were prepared via the ultrasonication method using Tween 80 as a nonionic surfactant. Lipid screening was conducted using Imwitor 491, Dynasan 118, and Apifil at concentrations of 2%, 4%, and 6%. The selected lipid (Apifil at 2%, 3%, 4%, and 5%) was melted at 100 °C, homogenized with the aqueous phase using a magnetic stirrer at 2000 rpm for 1 hour, cooled to 35 °C, and subjected to probe ultrasonication at 35 kHz for 5 minutes. The SLNs were characterized using a particle size analyzer and a UV-Vis spectrophotometer to evaluate storage stability, particle size, polydispersity index (PDI), entrapment efficiency, zeta potential, and DPPH free radical scavenging activity.
Results
Lipid screening revealed that Apifil-based formulations provided superior physical stability compared to Imwitor 491 and Dynasan 118. The optimized formulation, F7 (containing 2% Apifil), yielded the smallest particle size of 105.5±0.70 nm, a highly homogeneous PDI of 0.232, a zeta potential of -20.52 mV, and the highest entrapment efficiency at 73.56%. Furthermore, F7 demonstrated strong antioxidant activity with an IC50 value of 38.77 ppm, compared to pure myricetin (14.44 ppm).
Conclusion
The formulation of myricetin into Solid Lipid Nanoparticles using 2% Apifil via ultrasonication effectively minimizes particle size and maximizes entrapment efficiency. Although it exhibits lower long-term storage stability at room temperature, it successfully preserves potent antioxidant activity, offering a promising approach for health sciences and advanced drug delivery applications
Zitieren
APA
Rosida, D. Z., Dzakwan, M., & Ansory, H. M. (2026). Formulation and Characterization of Myricetin Solid Lipid Nanoparticles (SLNs) via Ultrasonication Method. Open Access Health Scientific Journal, 7(2), 253-258. https://doi.org/10.55700/oahsj.v7i2.235
Vancouver
Rosida DZ, Dzakwan M, Ansory HM. Formulation and Characterization of Myricetin Solid Lipid Nanoparticles (SLNs) via Ultrasonication Method. Open Access Health Scientific Journal. 2026;7(2):253-258. doi:10.55700/oahsj.v7i2.235
BibTeX
@article{Rosida2026,
author = {Rosida, Dewi Zulfa and Dzakwan, Muhammad and Ansory, Hery Muhamad},
title = {Formulation and Characterization of Myricetin Solid Lipid Nanoparticles (SLNs) via Ultrasonication Method},
journal = {Open Access Health Scientific Journal},
year = {2026},
volume = {7},
number = {2},
pages = {253--258},
doi = {10.55700/oahsj.v7i2.235}
}
EUVIMED